+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wound Antiseptics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 235 Pages
  • June 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5977499
Global wound antiseptics market expected to grow steadily, reaching a value of $780 million by 2031 from $580 million in 2024, with a compound annual growth rate (CAGR) of 4%. Explore the latest trends and forecasts in wound care solutions.

Growing Adoption Among Emerging Markets

The rising incidence of wounds is driving the increased penetration and adoption of wound antiseptics, especially among the middle-class population in emerging economies. Leading manufacturers are focusing on geographical expansion to capitalize on this trend. Companies like Reckitt Benckiser Group plc. are enhancing their market presence by collaborating with distributors and online sales channels, particularly in regions like India and China. This strategy has enabled them to maintain a strong market position and boost the sales of their wound antiseptic products, such as Dettol.

Impact of Aging Population and Associated Health Issues

The global increase in the geriatric population, coupled with a rise in diabetes and obesity, is directly linked to the growing prevalence of chronic wounds. Traditional wound care methods require extended healing periods and frequent dressing changes, which can be traumatic for patients. Advanced wound antiseptic products, however, offer significant benefits such as reduced contamination and faster healing times, which are expected to drive market growth.

Increased R&D and Strategic Collaborations

Leading manufacturers are actively pursuing inorganic growth strategies, including collaborations, to enhance research and development activities. These initiatives are anticipated to boost the demand for wound antiseptics. For instance, ConvaTec extended its wound care agreement with Vizient Inc. to provide advanced wound care products and services in the U.S., showcasing a commitment to improving wound management solutions.

Market Growth and Opportunities

The global wound antiseptics market has shown steady growth over the past five years and is expected to accelerate over the next decade. The market is projected to offer substantial opportunities, driven by the shift towards advanced wound care treatment options. Medical institutions' adoption of consistent wound management procedures results in shorter hospital stays and lower infection rates, promoting the use of advanced wound care treatments supported by clinical and economic data.

Focus on Developing Markets

Compared to developed regions, Latin America and Asia Pacific remain largely untapped markets with significant growth potential for wound antiseptics. Key players are increasingly focusing on strengthening their presence in these regions, given the large patient pool and growing elderly population. These markets offer substantial opportunities for manufacturers looking to expand their footprint and drive revenue growth.

Challenges in the Market

Despite the promising growth prospects, the wound antiseptics market faces several challenges. The high cost of advanced wound antiseptics can deter adoption, particularly in developing regions where cost-effective solutions are preferred. Additionally, product recalls due to component inconsistency, product failure, and packaging issues can hinder market growth.

Lack of Awareness in Developing Regions

A significant barrier to the adoption of wound antiseptics in developing regions is the lack of awareness about wound care management. Chronic wounds, such as diabetic foot ulcers, often go undiagnosed for extended periods, leading to severe complications. This delayed diagnosis is more prevalent in developing countries due to limited access to healthcare facilities and inadequate guidelines from government organizations.

Regional Insights

United States: A Leading Market

The U.S. wound antiseptics market dominates the North American region, driven by a rising prevalence of chronic wounds and supportive reimbursement policies. The increasing aging population and higher incidence of diabetes and obesity contribute to the demand for wound antiseptics in the country.

United Kingdom: Innovation Hub

The U.K. leads the European wound antiseptics market, with manufacturers focusing on developing innovative products that maintain moisture balance and offer prolonged antimicrobial activity. This focus on innovation is expected to drive market growth in the coming years.

China: Emerging Market

China represents a significant share of the East Asian wound antiseptics market. The growing elderly population and rising incidence of chronic wounds due to diabetes and cardiovascular diseases are expected to drive demand for wound antiseptics in the country.

Product Insights

Hydrogen peroxide-based wound antiseptics are anticipated to drive high market growth due to their strong sterilizing properties and adoption driven by stringent infection-control policies. Acute wounds account for a significant share of the market, supported by the increasing geriatric population, rising prevalence of diabetes, and growing investments in wound care research.

Competitive Analysis

  • Smith and Nephew
  • Johnson & Johnson Consumer Inc.
  • Reckitt Benckiser Group plc.
  • Angelini Pharma Inc.
  • 3M Company
  • Becton Dickenson & Company
  • Johnson & Johnson Services, Inc.
  • B. Braun Melsungen AG
  • Purdue Pharma L.P.
  • Ecolab
  • Schülke & Mayr GmbH
  • PSK Pharma Pvt. Ltd.

Key Segments Covered in Wound Antiseptics Industry Research

By Product Type:

  • PHMB
  • Povidone Iodine
  • Hydrogen Peroxide

By Form:

  • Wound Antiseptic Sprays
  • Wound Antiseptic Solutions
  • Wound Antiseptic Foams
  • Wound Antiseptic Wipes
  • Wound Antiseptic Gels

By Wound Type:

  • Antiseptics for Acute Wounds
  • Surgical Wounds
  • Traumatic Wounds
  • Antiseptics for Chronic Wounds
  • Vascular Ulcers
  • Diabetic Ulcers
  • Pressure Ulcers
  • Surgical Ulcers
  • Traumatic Ulcers
  • Wound Antiseptics for Burns

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long-term Care Centers
  • Home Care Settings

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Wound Antiseptics Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Disease Epidemiology
2.4. Regulatory Scenario
2.5. Reimbursement Landscape
2.6. Value Chain Analysis
2.7. Porter’s Five Forces Analysis
2.8. COVID-19 Impact Analysis
2.8.1. Supply
2.8.2. Demand
2.9. Economic Overview
2.9.1. World Economic Projections
2.10. PESTLE Analysis
3. Price Analysis, 2019 - 2023
3.1. Global Average Price Analysis, by Product Type, US$ Per Unit, 2019 - 2023
3.2. Prominent Factor Affecting Single-use Bronchoscopes Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit
4. Global Wound Antiseptics Market Outlook, 2019 - 2031
4.1. Global Wound Antiseptics Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
4.1.1. Key Highlights
4.1.1.1.1. PHMB
4.1.1.1.2. Povidone Iodine
4.1.1.1.3. Hydrogen Peroxide
4.2. Global Wound Antiseptics Market Outlook, by Form, Value (US$ Bn), 2019 - 2031
4.2.1. Key Highlights
4.2.1.1. Sprays
4.2.1.2. Solutions
4.2.1.3. Foams
4.2.1.4. Wipes
4.2.1.5. Gels
4.3. Global Wound Antiseptics Market Outlook, by Wound Type, Value (US$ Bn), 2019 - 2031
4.3.1. Key Highlights
4.3.1.1. Antiseptics for Acute Wounds
4.3.1.1.1. Surgical Wounds
4.3.1.1.2. Traumatic Wounds
4.3.1.2. Antiseptics for Chronic Wounds
4.3.1.2.1. Vascular Ulcers
4.3.1.2.2. Diabetic Ulcers
4.3.1.2.3. Pressure Ulcers
4.3.1.2.4. Surgical Ulcers
4.3.1.2.5. Traumatic Ulcers
4.3.1.3. Wound Antiseptics for Burns
4.4. Global Wound Antiseptics Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
4.4.1. Key Highlights
4.4.1.1. Hospitals
4.4.1.2. Ambulatory Surgical Centers
4.4.1.3. Clinics
4.4.1.4. Long-term Care Centers
4.4.1.5. Home Care Settings
4.5. Global Wound Antiseptics Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
4.5.1. Key Highlights
4.5.1.1. North America
4.5.1.2. Europe
4.5.1.3. Asia Pacific
4.5.1.4. Latin America
4.5.1.5. Middle East & Africa
5. North America Wound Antiseptics Market Outlook, 2019 - 2031
5.1. North America Wound Antiseptics Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.1.1. Key Highlights
5.1.1.1. PHMB
5.1.1.2. Povidone Iodine
5.1.1.3. Hydrogen Peroxide
5.2. North America Wound Antiseptics Market Outlook, by Form, Value (US$ Bn), 2019 - 2031
5.2.1. Key Highlights
5.2.1.1. Sprays
5.2.1.2. Solutions
5.2.1.3. Foams
5.2.1.4. Wipes
5.2.1.5. Gels
5.3. North America Wound Antiseptics Market Outlook, by Wound Type, Value (US$ Bn), 2019 - 2031
5.3.1. Key Highlights
5.3.1.1. Antiseptics for Acute Wounds
5.3.1.1.1. Surgical Wounds
5.3.1.1.2. Traumatic Wounds
5.3.1.2. Antiseptics for Chronic Wounds
5.3.1.2.1. Vascular Ulcers
5.3.1.2.2. Diabetic Ulcers
5.3.1.2.3. Pressure Ulcers
5.3.1.2.4. Surgical Ulcers
5.3.1.2.5. Traumatic Ulcers
5.3.1.3. Wound Antiseptics for Burns
5.4. North America Wound Antiseptics Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Ambulatory Surgical Centers
5.4.1.3. Clinics
5.4.1.4. Long-term Care Centers
5.4.1.5. Home Care Settings
5.5. North America Wound Antiseptics Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1. Key Highlights
5.5.1.1. U.S. Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.2. U.S. Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.3. U.S. Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.4. U.S. Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.5. Canada Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.6. Canada Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.7. Canada Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.1.8. Canada Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Europe Wound Antiseptics Market Outlook, 2019 - 2031
6.1. Europe Wound Antiseptics Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.1.1. Key Highlights
6.1.1.1. PHMB
6.1.1.2. Povidone Iodine
6.1.1.3. Hydrogen Peroxide
6.2. Europe Wound Antiseptics Market Outlook, by Form, Value (US$ Bn), 2019 - 2031
6.2.1. Key Highlights
6.2.1.1. Sprays
6.2.1.2. Solutions
6.2.1.3. Foams
6.2.1.4. Wipes
6.2.1.5. Gels
6.3. Europe Wound Antiseptics Market Outlook, by Wound Type, Value (US$ Bn), 2019 - 2031
6.3.1. Key Highlights
6.3.1.1. Antiseptics for Acute Wounds
6.3.1.1.1. Surgical Wounds
6.3.1.1.2. Traumatic Wounds
6.3.1.2. Antiseptics for Chronic Wounds
6.3.1.2.1. Vascular Ulcers
6.3.1.2.2. Diabetic Ulcers
6.3.1.2.3. Pressure Ulcers
6.3.1.2.4. Surgical Ulcers
6.3.1.2.5. Traumatic Ulcers
6.3.1.3. Wound Antiseptics for Burns
6.4. Europe Wound Antiseptics Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Ambulatory Surgical Centers
6.4.1.3. Clinics
6.4.1.4. Long-term Care Centers
6.4.1.5. Home Care Settings
6.5. Europe Wound Antiseptics Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1. Key Highlights
6.5.1.1. Germany Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.2. Germany Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.3. Germany Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.4. Germany Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.5. U.K. Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.6. U.K. Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.7. U.K. Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.8. U.K. Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.9. France Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.10. France Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.11. France Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.12. France Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.13. Italy Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.14. Italy Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.15. Italy Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.16. Italy Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.17. Turkey Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.18. Turkey Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.19. Turkey Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.20. Turkey Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.21. Russia Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.22. Russia Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.23. Russia Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.24. Russia Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.25. Rest of Europe Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.26. Rest of Europe Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.27. Rest of Europe Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.1.28. Rest of Europe Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Asia Pacific Wound Antiseptics Market Outlook, 2019 - 2031
7.1. Asia Pacific Wound Antiseptics Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.1.1. Key Highlights
7.1.1.1. PHMB
7.1.1.2. Povidone Iodine
7.1.1.3. Hydrogen Peroxide
7.2. Asia Pacific Wound Antiseptics Market Outlook, by Form, Value (US$ Bn), 2019 - 2031
7.2.1. Key Highlights
7.2.1.1. Sprays
7.2.1.2. Solutions
7.2.1.3. Foams
7.2.1.4. Wipes
7.2.1.5. Gels
7.3. Asia Pacific Wound Antiseptics Market Outlook, by Wound Type, Value (US$ Bn), 2019 - 2031
7.3.1. Key Highlights
7.3.1.1. Antiseptics for Acute Wounds
7.3.1.1.1. Surgical Wounds
7.3.1.1.2. Traumatic Wounds
7.3.1.2. Antiseptics for Chronic Wounds
7.3.1.2.1. Vascular Ulcers
7.3.1.2.2. Diabetic Ulcers
7.3.1.2.3. Pressure Ulcers
7.3.1.2.4. Surgical Ulcers
7.3.1.2.5. Traumatic Ulcers
7.3.1.3. Wound Antiseptics for Burns
7.4. Asia Pacific Wound Antiseptics Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Ambulatory Surgical Centers
7.4.1.3. Clinics
7.4.1.4. Long-term Care Centers
7.4.1.5. Home Care Settings
7.5. Asia Pacific Wound Antiseptics Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1. Key Highlights
7.5.1.1. China Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.2. China Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.3. China Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.4. China Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.5. Japan Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.6. Japan Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.7. Japan Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.8. Japan Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.9. South Korea Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.10. South Korea Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.11. South Korea Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.12. South Korea Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.13. India Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.14. India Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.15. India Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.16. India Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.17. Southeast Asia Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.18. Southeast Asia Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.19. Southeast Asia Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.20. Southeast Asia Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.21. Rest of Asia Pacific Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.22. Rest of Asia Pacific Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.23. Rest of Asia Pacific Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.1.24. Rest of Asia Pacific Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Latin America Wound Antiseptics Market Outlook, 2019 - 2031
8.1. Latin America Wound Antiseptics Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.1.1. Key Highlights
8.1.1.1. PHMB
8.1.1.2. Povidone Iodine
8.1.1.3. Hydrogen Peroxide
8.2. Latin America Wound Antiseptics Market Outlook, by Form, Value (US$ Bn), 2019 - 2031
8.2.1. Key Highlights
8.2.1.1. Sprays
8.2.1.2. Solutions
8.2.1.3. Foams
8.2.1.4. Wipes
8.2.1.5. Gels
8.3. Latin America Wound Antiseptics Market Outlook, by Wound Type, Value (US$ Bn), 2019 - 2031
8.3.1. Key Highlights
8.3.1.1. Antiseptics for Acute Wounds
8.3.1.1.1. Surgical Wounds
8.3.1.1.2. Traumatic Wounds
8.3.1.2. Antiseptics for Chronic Wounds
8.3.1.2.1. Vascular Ulcers
8.3.1.2.2. Diabetic Ulcers
8.3.1.2.3. Pressure Ulcers
8.3.1.2.4. Surgical Ulcers
8.3.1.2.5. Traumatic Ulcers
8.3.1.3. Wound Antiseptics for Burns
8.4. Latin America Wound Antiseptics Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Ambulatory Surgical Centers
8.4.1.3. Clinics
8.4.1.4. Long-term Care Centers
8.4.1.5. Home Care Settings
8.5. Latin America Wound Antiseptics Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1. Key Highlights
8.5.1.1. Brazil Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.2. Brazil Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.3. Brazil Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.4. Brazil Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.5. Mexico Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.6. Mexico Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.7. Mexico Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.8. Mexico Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.9. Argentina Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.10. Argentina Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.11. Argentina Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.12. Argentina Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.13. Rest of Latin America Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.14. Rest of Latin America Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.15. Rest of Latin America Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.1.16. Rest of Latin America Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Middle East & Africa Wound Antiseptics Market Outlook, 2019 - 2031
9.1. Middle East & Africa Wound Antiseptics Market Outlook, by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.1.1. Key Highlights
9.1.1.1. PHMB
9.1.1.2. Povidone Iodine
9.1.1.3. Hydrogen Peroxide
9.2. Middle East & Africa Wound Antiseptics Market Outlook, by Form, Value (US$ Bn), 2019 - 2031
9.2.1. Key Highlights
9.2.1.1. Sprays
9.2.1.2. Solutions
9.2.1.3. Foams
9.2.1.4. Wipes
9.2.1.5. Gels
9.3. Middle East & Africa Wound Antiseptics Market Outlook, by Wound Type, Value (US$ Bn), 2019 - 2031
9.3.1. Key Highlights
9.3.1.1. Antiseptics for Acute Wounds
9.3.1.1.1. Surgical Wounds
9.3.1.1.2. Traumatic Wounds
9.3.1.2. Antiseptics for Chronic Wounds
9.3.1.2.1. Vascular Ulcers
9.3.1.2.2. Diabetic Ulcers
9.3.1.2.3. Pressure Ulcers
9.3.1.2.4. Surgical Ulcers
9.3.1.2.5. Traumatic Ulcers
9.3.1.3. Wound Antiseptics for Burns
9.4. Middle East & Africa Wound Antiseptics Market Outlook, by End User, Value (US$ Bn), 2019 - 2031
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Ambulatory Surgical Centers
9.4.1.3. Clinics
9.4.1.4. Long-term Care Centers
9.4.1.5. Home Care Settings
9.5. Middle East & Africa Wound Antiseptics Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1. Key Highlights
9.5.1.1. GCC Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.2. GCC Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.3. GCC Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.4. GCC Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.5. South Africa Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.6. South Africa Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.7. South Africa Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.8. South Africa Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.9. Egypt Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.10. Egypt Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.11. Egypt Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.12. Egypt Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.13. Nigeria Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.14. Nigeria Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.15. Nigeria Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.16. Nigeria Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.17. Rest of Middle East & Africa Wound Antiseptics Market by Product Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.18. Rest of Middle East & Africa Wound Antiseptics Market by Form, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.19. Rest of Middle East & Africa Wound Antiseptics Market by Wound Type, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.1.20. Rest of Middle East & Africa Wound Antiseptics Market by End User, Value (US$ Bn) and Volume (Million Units), 2019 - 2031
9.5.2. BPS Analysis/Market Attractiveness Analysis
10. Competitive Landscape
10.1. Company Market Share Analysis, 2023
10.2. Competitive Dashboard
10.3. Company Profiles
10.3.1. Smith and Nephew
10.3.1.1. Company Overview
10.3.1.2. Product Portfolio
10.3.1.3. Financial Overview
10.3.1.4. Business Strategies and Development
10.3.2. Johnson & Johnson Consumer Inc.
10.3.2.1. Company Overview
10.3.2.2. Product Portfolio
10.3.2.3. Financial Overview
10.3.2.4. Business Strategies and Development
10.3.3. Reckitt Benckiser Group plc.
10.3.3.1. Company Overview
10.3.3.2. Product Portfolio
10.3.3.3. Financial Overview
10.3.3.4. Business Strategies and Development
10.3.4. Angelini Pharma Inc.
10.3.4.1. Company Overview
10.3.4.2. Product Portfolio
10.3.4.3. Financial Overview
10.3.4.4. Business Strategies and Development
10.3.5. 3M Company
10.3.5.1. Company Overview
10.3.5.2. Product Portfolio
10.3.5.3. Financial Overview
10.3.5.4. Business Strategies and Development
10.3.6. Johnson & Johnson Services, Inc.
10.3.6.1. Company Overview
10.3.6.2. Product Portfolio
10.3.6.3. Financial Overview
10.3.6.4. Business Strategies and Development
10.3.7. B. Braun Melsungen AG
10.3.7.1. Company Overview
10.3.7.2. Product Portfolio
10.3.7.3. Financial Overview
10.3.7.4. Business Strategies and Development
10.3.8. Purdue Pharma L.P.
10.3.8.1. Company Overview
10.3.8.2. Product Portfolio
10.3.8.3. Financial Overview
10.3.8.4. Business Strategies and Development
10.3.9. Ecolab
10.3.9.1. Company Overview
10.3.9.2. Product Portfolio
10.3.9.3. Financial Overview
10.3.9.4. Business Strategies and Development
10.3.10. Schülke & Mayr GmbH
10.3.10.1. Company Overview
10.3.10.2. Product Portfolio
10.3.10.3. Financial Overview
10.3.10.4. Business Strategies and Development
10.3.11. PSK Pharma Pvt. Ltd.
10.3.11.1. Company Overview
10.3.11.2. Product Portfolio
10.3.11.3. Financial Overview
10.3.11.4. Business Strategies and Development
11. Appendix
11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations

Companies Mentioned

  • Smith and Nephew
  • Johnson & Johnson Consumer Inc.
  • Reckitt Benckiser Group plc.
  • Angelini Pharma Inc.
  • 3M Company
  • Becton Dickenson & Company
  • Johnson & Johnson Services, Inc.
  • B. Braun Melsungen AG
  • Purdue Pharma L.P.
  • Ecolab
  • Schülke & Mayr GmbH
  • PSK Pharma Pvt. Ltd.

Methodology

Loading
LOADING...